Ritonavir Completed Phase 4 Trials for Drug Drug Interaction (DDI) Basic Science

IndicationsStatusPurposePhase
CompletedBasic Science4
clinicaltrials.gov IdentifierTitleDrugs
NCT04531072Effect of Atazanavir-ritonavir on the Pharmacokinetics and Toxicity of Lumefantrine